Mahsa Samangooei

Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing–remitting multiple sclerosis patients and their first-degree family

M. Etemadifar, M. Farjam, M. Meshkibaf, 2021, Metabolic Brain Disease.

Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing–remitting multiple sclerosis patients and their family members

M. Etemadifar, M. Farjam, Bahram Movahedi, 2022, Scientific Reports.